Atomo Diagnostics Limited (ASX:AT1)
Australia · Delayed Price · Currency is AUD 0.0160
-0.0010 (-5.88%)
Oct 28, 2026, 9:59 AM AEDT
Atomo Diagnostics Market Cap
Atomo Diagnostics has a market cap or net worth of 14.44 million as of October 27, 2026. It is the 41,016th most valuable company in the world and the 1,160th biggest in Australia. Its market cap has decreased by 33.99% in one year.
Market Cap
14.44M
Enterprise Value
11.10M
Revenue
5.33M
Global Rank
Country Rank
#1,160 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since April 16, 2020, Atomo Diagnostics's market cap has decreased from 218.82M to 14.44M, a decrease of -93.40%. That is a compound annual growth rate of -34.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 15.34M | -47.40% |
| Dec 31, 2025 | 29.17M | 140.15% |
| Dec 31, 2024 | 12.14M | -13.64% |
| Dec 29, 2023 | 14.06M | -54.38% |
| Dec 30, 2022 | 30.83M | -81.93% |
| Dec 31, 2021 | 170.58M | -1.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cleo Diagnostics | 43.88M |
| Nova Eye Medical | 42.74M |
| HeraMED | 41.71M |
| Micro-X | 39.13M |
| CleanSpace Holdings | 38.49M |
| Control Bionics | 30.41M |
| OncoSil Medical | 26.43M |
| CurveBeam AI | 16.13M |